Higher MCM7 expression is always associated with high proliferative capacity in the early stage of cancer.42 In contrast, in late-stage cancer patients, many confounding factors, including tumor size, vascular or lymphocyte invasion, can affect the prognostic values of MCM7 that might produce a nonsignificant result. This evidence concerns the gene MCM7 and neoplasm.